Wealthspire Advisors (Maryland)’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-6,525
Closed -$234K 493
2019
Q4
$234K Sell
6,525
-9,349
-59% -$348K 0.02% 440
2019
Q3
$555K Sell
15,874
-235
-1% -$9.04K 0.04% 243
2019
Q2
$693K Buy
16,109
+85
+0.5% +$3.52K 0.05% 199
2019
Q1
$691K Sell
16,024
-2,508
-14% -$101K 0.05% 199
2018
Q4
$677K Sell
18,532
-147
-0.8% -$5.46K 0.06% 168
2018
Q3
$750K Buy
18,679
+7,964
+74% +$318K 0.06% 178
2018
Q2
$411K Sell
10,715
-62
-0.6% -$2.28K 0.04% 281
2018
Q1
$369K Sell
10,777
-22
-0.2% -$772 0.03% 311
2017
Q4
$354K Buy
10,799
+3,640
+51% +$125K 0.03% 336
2017
Q3
$239K Buy
7,159
+3
+0% +$103 0.03% 420
2017
Q2
$254K Buy
7,156
+1,484
+26% +$50.1K 0.03% 384
2017
Q1
$174K Buy
+5,672
New +$175K 0.02% 437

Other funds holding QGEN

Wealthspire Advisors (Maryland)'s QGEN Position: Q1 2020 in Review

Wealthspire Advisors (Maryland) sold out of Qiagen (QGEN) in Q1 2020, closing a stake of 6,525 shares — an estimated $234K sold.

Wealthspire Advisors (Maryland) first reported a position in QGEN in Q1 2017 and held it in 12 quarters. The position peaked at $750K in Q3 2018. 259 funds tracked by Wall St. Rank hold QGEN as of Q1 2020.

  • Wealthspire Advisors (Maryland) reported no remaining Qiagen position as of Q1 2020 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 6,525 Qiagen shares in Q1 2020, an estimated $234K.
  • Wealthspire Advisors (Maryland) first reported a position in Qiagen in Q1 2017 and held it in 12 quarters.
  • Wealthspire Advisors (Maryland)'s Qiagen position peaked at $750K in Q3 2018.
  • 259 funds tracked by Wall St. Rank held Qiagen as of Q1 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q1 2020, filed 13 May 2020.